EQR
64
2
VFC
40
-2
EXPD
53
2
GD
63
4
WU
28
-4
ADI
65
3
PHM
63
-2
WMB
58
2
HSIC
44
5
FITB
48
3
STT
44
4
PVH
59
-3
HP
33
3
ESS
79
2
AZO
52
2
PRGO
36
-3
EW
36
8
HOG
33
2
CRM
49
2
WBA
34
7
EQR
64
2
VFC
40
-2
EXPD
53
2
GD
63
4
WU
28
-4
ADI
65
3
PHM
63
-2
WMB
58
2
HSIC
44
5
FITB
48
3
STT
44
4
PVH
59
-3
HP
33
3
ESS
79
2
AZO
52
2
PRGO
36
-3
EW
36
8
HOG
33
2
CRM
49
2
WBA
34
7
Financhill
Back

Akamai Technologies Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Buy
56

AKAM
Akamai Technologies

Last Price:
89.35
Seasonality Move:
-2.51%
Sell
35

RARE
Ultragenyx Pharmaceutical

Last Price:
38.01
Seasonality Move:
3.65%
Buy
56
Akamai Technologies (AKAM) is a Buy

Is Akamai Technologies a Buy, Sell or Hold?

  • The current Akamai Technologies [AKAM] share price is $88.48. The Score for AKAM is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
  • AKAM is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
35
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $37.42. The Score for RARE is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

AKAM Stock Price Chart

What is Akamai Technologies's stock price today?

  • The Akamai Technologies share price today is $88.48
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AKAM is experiencing selling pressure, which indicates risk of future bearish movement.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $37.42
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing selling pressure, which indicates risk of future bearish movement.

AKAM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.37 Sell
Relative Strength Index (14 RSI): 33.92 Sell
Chaikin Money Flow: -1104251 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (89.22 - 94.4) Sell
Bollinger Bands (100): (94.3 - 115.38) Sell

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.58 Sell
Relative Strength Index (14 RSI): 37.74 Sell
Chaikin Money Flow: -836354 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (39.26 - 42.36) Sell
Bollinger Bands (100): (41.26 - 48.86) Sell

AKAM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 89.08 Sell
20-day SMA: 90.96 Sell
50-day SMA: 96.52 Sell
200-day SMA: 108.12 Sell
8-day EMA: 89.23 Sell
20-day EMA: 91.13 Sell
50-day EMA: 96.06 Sell
200-day EMA: 103.01 Sell

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 41.11 Sell
20-day SMA: 40.61 Sell
50-day SMA: 42.43 Sell
200-day SMA: 42.45 Sell
8-day EMA: 40.32 Sell
20-day EMA: 40.92 Sell
50-day EMA: 42.29 Sell
200-day EMA: 43.55 Sell

Akamai Technologies Earnings Growth & AKAM Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.05 per share, an increase next quarter of $0.12 per share, an increase this year of $0.21 per share, and an increase next year of $0.44 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.01 per share, an increase this year of $0.90 per share, and an increase next year of $1.07 per share.

Akamai Technologies Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):